<DOC>
	<DOCNO>NCT00296829</DOCNO>
	<brief_summary>All market influenza vaccine inject intramuscular route . This study test whether influenza vaccine effective inject route muscle . In order prove , amount antibody blood measure vaccination . In addition , safety influenza vaccine test evaluate serious reaction occur vaccination . The vaccine inject study similar sponsor 's market intramuscular influenza vaccine ( Vaxigrip ) . Primary Objective : To demonstrate compare immune response two dosage influenza vaccine administer alternate route intramuscular administration vaccine . Secondary Objectives : - To compare immune response 21 day vaccination investigational group versus intramuscular group influenza strain . - To describe safety profile vaccination study group - To describe compliance two dosage vaccine administer alternate route European Medicine Agency . Observational Objectives : - To describe safety profile 21-day period follow intramuscular revaccination group possibility reaction first injection site . - To describe pain injection site Visual Analog Scale acceptability injection use questionnaire group . - To describe leakage appear injection site immediately alternate route injection explore relationship immunogenicity . - To evaluate cellular mediate immune response subset subject .</brief_summary>
	<brief_title>Immunogenicity Two Dosages Inactivated , Split-Virion Influenza Vaccine Given Alternate Route Elderly</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Orthomyxoviridae Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Aged 60 85 year day inclusion Informed consent form sign Able attend schedule visit comply trial procedure . Systemic hypersensitivity egg protein , chick protein , vaccine component , particular , neomycin , formaldehyde , octoxinol 9 , history lifethreatening reaction trial vaccine vaccine contain substance Febrile illness ( oral temperature &gt; = 37.5°C equivalent rectal temperature &gt; = 38.0°C ) day inclusion Any vaccination participation another clinical trial four week precede first trial vaccination Planned participation another clinical trial present trial period Congenital acquire immunodeficiency , immunosuppressive therapy anticancer chemotherapy radiation therapy within precede six month , longterm systemic corticosteroid therapy Chronic illness stage could interfere trial conduct completion Current abuse alcohol drug addiction may interfere subject 's ability comply trial procedure Blood bloodderived product receive past three month Vaccination plan four week follow first trial vaccination Previous vaccination influenza ( previous six month ) trial vaccine another vaccine Thrombocytopenia bleeding disorder contraindicate intramuscular vaccination Subject deprive freedom administrative court order , emergency setting , hospitalize without his/her consent .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Influenza ;</keyword>
	<keyword>Orthomyxoviruses ;</keyword>
	<keyword>Inactivated Split-virion influenza vaccine ;</keyword>
	<keyword>Elderly .</keyword>
</DOC>